Works cited GLP-1 Analogues Market Size & Growth Forecast to 2033 MarketsandMarkets, accessed February 2, 2026, GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market Global Forecast to 2033: With the Semaglutide Patent Expiring in 2026 Onwards, the Biosimilars Market is Expected to Grow Significantly GlobeNewswire, accessed February 2, 2026, GLP-1 Receptor Agonists and Patent Strategy: Securing Patent , accessed February 2, 2026, Are GLP-1s about to dethrone oncology as pharmas biggest segment
Stay active Walking, cycling, swimming, or other regular physical activities promote healthy digestion and regular bowel movements
GLP-1RA and risks of substance use disorders among US veterans with type 2 diabetes: A cohort study
This is a rookie-level mistake still being made with Semaglutide and Tirzepatide, and it wont surprise me to see this idiocy continue to happen once Retatrutide is FDA-approved
Notice the characteristic "sawtooth" pattern with significant variation between injection days
G., Aras, M., Kumar, R
